NASDAQ · Financial Statements

CollPlant Biotechnologies Ltd (OPHI) Revenue, Earnings & Financial Statements

$3.58 NASDAQ: OPHI Market Cap $6.76M

Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)

Full income statement, balance sheet, and cash flow statement for CollPlant Biotechnologies Ltd (OPHI), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Revenue and earnings of other Medical - Specialties stocks

ALC revenue $10.4BSTE revenue $5.9BMLAB revenue $249.0MQDEL revenue $2.7BMOBI stockSI stockMASS revenue $56.0MANIK revenue $113.0MAPYX revenue $53.0MSKIN revenue $301.0MAll Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
OPHI Overview OPHI Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.